Introduction to Endocrinology & Receptor-Hormone Interactions

Comparative Regulatory Systems of the Human Body

The body utilizes two primary, complementary systems to communicate and coordinate activities to maintain homeostasis: the endocrine system and the nervous system.

Comparison of Nervous and Endocrine Systems

Key Similarities

1. Central Nervous System Association: Both systems are closely associated with the brain, specifically the hypothalamus.
2. Shared Chemical Messengers: Certain chemicals serve as both neurotransmitters and hormones. Examples include epinephrine and dopamine.
3. Cooperation: The systems are cooperative. The nervous system can secrete neuroendocrine peptides (neurohormones) into the circulatory system. Conversely, certain parts of the endocrine system, such as the adrenal glands, are directly innervated by the nervous system.

Key Differences

1. Mode of Transport:     * Nervous System: Transports via axons. Path is specific (point-to-point) with a limited range of targets.     * Endocrine System: Transports via the blood. Path is non-specific (systemic delivery), allowing for a broad range of targets throughout the body.
2. Chemical Messengers:     * Nervous System: Uses neurotransmitters secreted by neurons.     * Endocrine System: Uses hormones secreted by endocrine cells or glands.
3. Speed of Response:     * Nervous System: Rapid-onset speed.     * Endocrine System: Slow-onset speed.
4. Duration of Response:     * Nervous System: Short-lasting effect.     * Endocrine System: Long-lasting effect.

Anatomy of the Endocrine System

Hormones are chemical substances secreted into the blood that exert biological effects on target cells to maintain homeostasis.

Classical Endocrine Glands and Their Secretions

Nonclassical Endocrine Organs and Their Hormones

Many organs not primarily known as endocrine glands produce chemical messengers that act as hormones:

• Brain (Hypothalamus): Corticotropin-releasing hormone (CRH), thyrotropin-releasing hormone (TRH), luteinizing hormone-releasing hormone (LHRH), growth hormone-releasing hormone (GHRH), somatostatin, and various growth factors (FGFs, TGF-$\alpha$, TGF-$\beta$, IGF-I).
• Heart: Atrial natriuretic peptides.
• Kidney: Erythropoietin, renin, $1,25$-dihydroxyvitamin D.
• Liver (and other organs/fibroblasts): IGF-I.
• Adipose Tissue: Leptin.
• Gastrointestinal Tract: Cholecystokinin (CCK), gastrin, secretin, vasoactive intestinal peptide (VIP), enteroglucagon, gastrin-releasing peptide.
• Platelets: Platelet-derived growth factor (PDGF), TGF-$\beta$.
• Macrophages/Lymphocytes: Cytokines, TGF-$\beta$, proopiomelanocortin (POMC)-derived peptides.
• Various Sites: Epidermal growth factor (EGF), TGF-$\alpha$, neuregulins, neurotrophins.

Hormone Classification and Plasma Half-Life

Chemical Types of Hormones

1. Tyrosine-derived (Amines): Amino acids modified for unique functions (e.g., Epinephrine, Thyroxine).
2. Peptides and Proteins: Chains of linked amino acids, varying from short to long (e.g., Insulin, GH, Oxytocin, Somatostatin).
3. Steroids: Derived from the structure of cholesterol; these are lipophilic (e.g., Estradiol, Progesterone, Testosterone).

Plasma Half-Life Statistics

The circulating lifespan of hormones varies significantly based on their chemical structure:

• Amines: $2-3\,\text{min}$.
• Thyroid Hormones:     * $T_4$: $6.7\,\text{days}$.     * $T_3$: $0.75\,\text{days}$.
• Polypeptides: $4-40\,\text{min}$.
• Proteins: $15-170\,\text{min}$.
• Steroids: $4-120\,\text{min}$.

Regulation of Hormone Secretion

Feedback Loops

Hormone levels are primarily controlled by feedback loops, typically negative feedback where an elevated end-product inhibits the production of its stimulation factor.

• Example 1: Elevated thyroid hormones decrease TSH production.
• Example 2: Elevated testosterone levels decrease LH production.

Short vs. Long Feedback Loops

• Short Feedback Loop: The product of the target organ inhibits the pituitary stimulating factor (e.g., cortisol inhibits ACTH release).
• Long Feedback Loop: The product of the target organ inhibits the hypothalamic release factor (e.g., cortisol inhibits CRH release).

Functions and Pathologies

Major Physiological Roles

1. Internal Environment Maintenance:     * Fluid/Electrolytes/Blood Pressure: Regulated by ADH, aldosterone, and ANP.     * Plasma Calcium/Phosphate: Regulated by PTH, calcitonin, and Vitamin D.     * Bone Repair/Mineralization: Regulated by PTH, GH, insulin, sex steroids, and cortisol.
2. Energy Balance:     * Involves fuel utilization, storage (surplus), and mobilization of stores.     * Key hormones: Insulin, epinephrine, glucagon, thyroid hormone.
3. Growth and Development:     * Controls timing, progression, and physical size of organs and the body.     * Key hormones: GH, sex steroids, insulin, thyroid hormone.
4. Reproduction:     * Maintenance of organs, gamete development, sexual behavior, and phenotypic differences.     * Processes: Ovulation, spermatogenesis, fertilization, pregnancy, birth, lactation.     * Key hormones: GnRH, FSH, LH, estrogen, testosterone, inhibin, progesterone.

Endocrine Pathologies

• Hypersecretion: Excessive secretion of a hormone.
• Hyposecretion: Insufficient secretion of a hormone.
• Primary Disease: Arises from a problem within the gland that produces the final hormone.
• Secondary Disease: Arises from problems in regulatory factors (e.g., hypothalamus or pituitary) that alter the activity of an otherwise healthy gland.
• Insensitivity: Defects in the receptor or post-receptor signaling that prevent or alter the hormone's effect.

Clinical Examples

• Vitamin D Deficiency: Leads to Rickets or Osteoporosis.
• Metabolic: Diabetes Mellitus, Hypo/hyper-thyroidism.
• Growth: Gigantism (pre-puberty GH excess), Acromegaly (post-puberty GH excess).
• Reproductive: Primary Ovarian Insufficiency, Androgen Insensitivity Syndrome (AIS).     * AIS Detail: In XY individuals, an androgen receptor defect prevented testosterone from exerting effects, leading to a mature female phenotype via aromatase conversion of testosterone to estrogen.

Hormone-Receptor Interaction Principles

Transport and Solubility Patterns

Polar Hormones (Peptides, Proteins, some Amines)

• Nature: Water-soluble.
• Transport: Dissolved free in state/serum.
• Action: Cannot cross the cell plasma membrane. Binds to Cell Membrane Receptors.
• Mechanism: Indirectly activates signaling processes (second messengers) to regulate cell activity.

Apolar/Non-polar Hormones (Steroids, Thyroid Hormones)

• Nature: Low solubility in water; lipophilic.
• Transport: Requires Carrier Proteins (Serum Binding Proteins).
• Action: Dissociates from carriers and diffuses directly through the plasma membrane.
• Mechanism: Binds to Intracellular Receptors (cytoplasmic or nuclear) to regulate gene expression.

Mathematical Properties of Binding

Hormone-receptor interactions are simple, reversible, bimolecular reactions occurring at physiological concentrations of $10^{-7}$ to $10^{-12}\,\text{M}$.

The equilibrium of hormone ($H$) and transport protein ($P$) or receptor is expressed as: $[H] + [P] \rightleftharpoons [HP]$

Dissociation Constant ($K_D$):$K_D = \frac{[H][P]}{[HP]}$

• The $K_D$ represents the concentration of free hormone at which $50\%$ of receptors are bound.
• Free Hormone: The biologically active form. Binding to proteins regulates the availability of this active form.

Cell Membrane Receptor Signaling

Cell membrane receptors communicate signals through three main classes of signaling systems.

1. G-Protein Linked Receptors

These are 7-Transmembrane Helix Receptors (GPCRs). There are over 800 types, targeted by $100+$ approved medications.

G-Protein Types and Effectors

G-proteins are hetero-trimeric GTPases consisting of $\alpha$, $\beta$, and $\gamma$ subunits. The $\alpha$ subunit determines the effector:

• $G_s$: Activates Adenylate Cyclase.
• $G_q$: Activates Phospholipase C.
• $G_i$: Modulates Ion Channels.
• $G_t$: Activates $cGMP$ phosphodiesterase.

The G-Protein Cycle

1. Inactive state: $\alpha$ subunit is bound to $GDP$.
2. Hormone binds to receptor, triggering exchange of $GDP$ for $GTP$ on the $\alpha$ subunit.
3. The $\alpha$-$GTP$ complex dissociates from $\beta\gamma$ and activates effectors (e.g., Adenylate Cyclase or Phospholipase C).
4. Second messengers ($cAMP$, $DAG$, $IP_3$) are produced.
5. Internal GTPase activity of the $\alpha$ subunit hydrolyzes $GTP$ back to $GDP$, inactivating the protein.

Second Messenger Example: Adenylate Cyclase

• Hormone binding -> $G_{\alpha\beta\gamma}$ activation -> Adenylate Cyclase.
• Adenylate Cyclase converts $ATP$ to $cAMP$.
• $cAMP$ activates Protein Kinase A (PKA).
• PKA phosphorylates proteins to alter cellular activity.

2. Kinase-Linked Receptors

These are typically single-pass transmembrane proteins that dimerize upon ligand binding.

• Receptor Tyrosine Kinase (RTK): Examples include insulin and growth factors. Binding causes dimerization and Trans Auto-Phosphorylation of tyrosine residues. This recruits accessory effector proteins for signal transduction (cell growth, gene regulation). These are often targets for chemotherapy.
• Janus Kinase (JAK) Receptor: Used by Growth Hormone. The receptor lacks intrinsic kinase activity but recruits JAK (named after Janus, the god of beginnings/endings). JAK activates STAT (Signal Transducer and Activator of Transcription), which moves to the nucleus to regulate gene expression.

3. Calcium-Calmodulin Linked

Involves the release of calcium as a secondary messenger to activate calmodulin-dependent processes.

Intracellular Receptors and Genomic Action

Lipophilic hormones (steroids and thyroid hormones) act through the Steroid Hormone Receptor Superfamily.

Receptor Structure

These receptors contain common structural domains:

• N-terminal: Transactivation domain.
• DNA-Binding Domain: Feature "Zinc Fingers" (stabilized by $Zn$ atoms) that intercalate into the DNA.
• C-terminal: Hormone binding, dimerization, and transactivation domains.

Mechanism of Action

1. Hormone dissociates from carrier protein and enters the cell.
2. Hormone binds to an intracellular receptor, often stabilized by Heat Shock Proteins (which dissociate upon binding).
3. The hormone-receptor complex dimerizes.
4. The dimer enters the nucleus and binds to a specific Hormone Response Element (HRE) on the DNA.     * Example HRE sequence: $5'\,AGAACAnnnTGTTCT\,3'$.
5. Binding regulates the transcription of mRNA, leading to the synthesis of new proteins/enzymes.

Modulation of Cellular Sensitivity

Cells can regulate their response to hormones through three primary mechanisms:

1. Down-regulation: A decrease in the total number of membrane receptors in response to high levels of hormone.
2. Desensitization: The chemical modification of the receptor (e.g., phosphorylation by $\beta$-Adrenergic Receptor Kinase) which blocks its interaction with G-proteins.
3. Negative Cooperativity: A phenomenon where increasing receptor occupancy decreases the affinity of the remaining empty receptors for the hormone.
4. Receptor-Mediated Endocytosis: Hormone binding triggers the internalization of the receptor-hormone complex. Receptors may then be degraded or recycled back to the membrane.

Questions & Discussion

• Q: Which of the following is uniquely associated with the endocrine system?     * A. Chemical messengers     * B. Systemic delivery     * C. Rapid onset     * D. Specific receptors     * Answer: B. Systemic delivery (Nervous system is targeted; systemic transport via blood is unique to endocrine function).

• Q: Which statement is TRUE?     * A. For $100\%$ biological effect of a hormone, all its receptors must be bound     * B. $ED_{50}$ is the concentration required for $50\%$ of receptors to be bound     * C. A larger $K_D$ would mean more free hormone     * D. Polar hormones have intracellular receptors     * Answer: C. A larger $K_D$ would mean more free hormone (Higher $K_D$ indicates lower affinity, requiring higher concentrations of free hormone to achieve half-saturation).

• Q: Which of the following would be an example of a primary hypo-secretion?     * A. Acromegaly     * B. Androgen insensitivity syndrome     * C. Gigantism     * D. Osteoporosis     * Answer: D. Osteoporosis (Note: Acromegaly/Gigantism are hyper-secretion; AIS is insensitivity).

• Q: Membrane receptors:     * A. are activated by lipophilic hormones     * B. pass through the membrane 7 times     * C. dimerize to recruit kinases (i.e. JAK)     * D. facilitate signal amplification     * Correct Answers: B, C, and D are all characteristics of various membrane receptors.

• Q: Which is FALSE of Thyroxine ($T_4$)?     * A. It is regulated by negative feedback     * B. It requires a plasma carrier protein     * C. It is a steroid hormone     * D. It has a half life of days     * Answer: C. It is a steroid hormone (False. $T_4$ is an amine hormone derived from tyrosine, although it behaves like a steroid in transport and receptor binding).